Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X:
“The Human+AI Oncology Trial (Nature Communications, 2026)
AI will not be sufficient on its own as long as it cannot humanize.
Randomized prescreening study (N=355):
Accuracy
- Human: 71.5%
- AI: 59.9%
- Human+AI: 76.1%
Where did AI perform well in The Human+AI Oncology Trial?
- Biomarker extraction
- Staging (T/N/M)
- Response assessment
Where did it struggle?
- ECOG performance status
- Context-heavy clinical judgment
- Automation bias risk
Faster?
No. More accurate (with humans)? Yes. ”
Read the full articles here.
Other OncoDaily articles featuring Ahmet Dirican.